GlassScriptPhysician profile
Kristi L Harrison
NPI 1306245261
$10,559.01
in general payments reported to CMS, 2019-2025
48 companies · $2,252 in 2025
The $2,252 reported for 2025 was more than what 98% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,753 · 2022: $2,132 · 2023: $2,385 · 2024: $2,037 · 2025: $2,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,575 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,574.63 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,733.17 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,511.65 | 2021-2025 | |
| Lilly USA, LLC | $908.69 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $775.69 | 2021-2025 | Repatha, Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $547.57 | 2021-2025 | Xifaxan, Trulance |
| Astrazeneca Pharmaceuticals LP | $543.20 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $368.65 | 2022-2024 | |
| Corium, LLC | $351.14 | 2022-2023 | Azstarys |
| Pfizer INC. | $343.63 | 2021-2025 | |
| Glaxosmithkline, LLC. | $318.85 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $302.90 | 2021-2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $273.51 | 2023-2025 | Rexulti, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $209.70 | 2021-2024 | Xarelto, Spravato |
| Antares Pharma, INC. | $203.03 | 2021-2025 | Xyosted |
| Teva Pharmaceuticals USA, INC. | $168.18 | 2021-2023 | Austedo, Ajovy |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristi Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.